Welcome to visit Intco Medical official website !

CONTACT US
INTCO Medical 2025 Annual Report
TIME: 2026-04-25 FROM: INTCO Medical

Advancing as a Global Healthcare Leader with Strong Financial Resilience

INTCO Medical has released its 2025 Annual Report, presenting a year of steady growth, operational resilience, and continued global expansion. As the world’s largest non-latex glove manufacturer and a leading healthcare solutions provider, the company continues to strengthen its position across medical consumables, Rehabilitation Medical Equipment, and physical therapy.

In 2025, INTCO Medical achieved total revenue of RMB 9.926 billion, representing a 4.23% year-over-year increase. Despite external market fluctuations, the company maintained strong operational discipline, with operating cash flow increasing by 74.69% to RMB 1.885 billion. Net assets attributable to shareholders reached RMB 18.254 billion, reflecting long-term financial stability and sustainable growth capability.

This performance highlights the company’s ability to balance scale, efficiency, and innovation while navigating an increasingly complex global healthcare environment, as further reflected on the INTCO Medical.


INTCO Medical 2025 Annual Report Highlights Growth

World’s Largest Non-Latex Glove Manufacturer Expands Global Supply

A central driver of INTCO Medical’s continued growth is its leadership as the world’s largest non-latex glove manufacturer. The company has built an annual production capacity of 103 billion disposable gloves, including 70 billion nitrile gloves and 33 billion PVC gloves, ensuring reliable and large-scale global supply.

This unmatched manufacturing scale positions INTCO Medical at the forefront of the non-latex glove industry, supporting critical applications across healthcare, food safety, industrial protection, and public health sectors. Its extensive portfolio of disposable gloves continues to evolve through innovation in materials and production processes.

Through advanced automation, intelligent manufacturing systems, and strict quality control standards, INTCO Medical consistently delivers high-performance products that meet international regulatory requirements. This capability reinforces its global reputation as a trusted supplier in the non-latex glove market.

Building a Diversified Healthcare Portfolio Beyond Gloves

While disposable gloves remain the core business, INTCO Medical has expanded into a broader healthcare ecosystem that includes Rehabilitation Medical Equipment and physical therapy products. This strategic diversification strengthens the company’s ability to serve multiple healthcare needs across global markets.

The company’s manufacturing capacity includes approximately 1 million manual wheelchairs and 100,000 electric wheelchairs annually, supported by advanced production equipment and standardized manufacturing processes. These products are widely used in rehabilitation centers, hospitals, and home care environments.

By integrating Rehabilitation Medical Equipment with its medical consumables portfolio, INTCO Medical enhances its ability to provide comprehensive healthcare solutions, reinforcing its role as a global healthcare platform rather than a single-category manufacturer.

Global Manufacturing and Supply Chain Excellence

INTCO Medical operates a highly coordinated global manufacturing network, with 10 major R&D and production bases across China and overseas. These facilities support the large-scale production of medical consumables, physical therapy products, and Rehabilitation Medical Equipment.

Key manufacturing bases are strategically located to optimize efficiency, reduce supply chain risks, and ensure stable delivery across regions. The company’s international footprint is further supported by global marketing centers in North America, Europe, and Asia, enabling rapid response to customer needs.

More information about its global operations and strategic positioning can be found on the company overview, which outlines its long-term vision and development strategy.

Driving Innovation Through AI and R&D Investment

Innovation remains a core pillar of INTCO Medical’s long-term growth. In 2025, the company accelerated the integration of artificial intelligence and big data technologies across its operations, improving manufacturing efficiency, product quality, and decision-making processes.

INTCO Medical invested RMB 404 million in research and development, representing 4.07% of total revenue. The company and its subsidiaries now hold 298 patents, reflecting strong capabilities in material science, product design, and process optimization.

New product innovations, including advanced synthetic gloves and enhanced protective solutions, demonstrate the company’s commitment to meeting evolving global healthcare demands while maintaining its leadership in non-latex gloves.

INTCO Medical Leads Global Non-Latex Glove Market

Expanding Global Reach and Brand Influence

INTCO Medical continues to expand its presence in global markets, with products now sold in more than 150 countries and regions. The company serves over 15,000 clients worldwide, supported by a global marketing team of more than 500 professionals.

In 2025, INTCO Medical participated in 27 international exhibitions, strengthening brand visibility and building long-term partnerships with distributors and industry stakeholders. The company also maintains active engagement through platforms such as LinkedIn and YouTube, enhancing its global communication and brand reach.

Its multi-channel strategy, combining traditional distribution networks and digital platforms, ensures strong market penetration and continuous growth across regions.

For business cooperation and partnership opportunities, the contact page provides direct access to INTCO Medical’s global team.

ESG Commitment and Recognized Global Standards

INTCO Medical continues to integrate environmental, social, and governance principles into its operations, reinforcing its commitment to sustainable and responsible development.

In 2025, the company advanced its green transformation through clean energy initiatives and ongoing optimization of its energy structure. These efforts contribute to reduced environmental impact and improved operational sustainability.

INTCO Medical received multiple globally recognized certifications and honors, including the EcoVadis “COMMITTED” Badge 2025, WIND ESG Rating A, BSCI Certification, and WRAP Certification. It was also included in the “ESG 100 Index of Chinese Enterprises 2025” and recognized as an ESG Leader in the Bloomberg Green Finance 2026 Watchlist by Bloomberg Businessweek.

These achievements demonstrate the company’s commitment to international standards, responsible manufacturing, and long-term stakeholder value.

Outlook: Strengthening Global Leadership in Non-Latex Gloves and Healthcare

Looking ahead, INTCO Medical will continue to build on its strengths in manufacturing scale, technological innovation, and global operations. As global demand for non-latex gloves and healthcare solutions continues to grow, the company is well-positioned to expand its leadership as the world’s largest non-latex glove manufacturer.

By focusing on quality, efficiency, and innovation, INTCO Medical aims to create a more resilient and sustainable global healthcare supply system while deepening its connections with customers and partners worldwide.

FAQ

How does INTCO Medical position itself in the global healthcare industry?

INTCO Medical positions itself as the world’s largest non-latex glove manufacturer while building a comprehensive global healthcare platform that integrates medical consumables, Rehabilitation Medical Equipment, and physical therapy solutions.

What is the production capacity of INTCO Medical?

INTCO Medical has built large-scale manufacturing capabilities, including an annual production capacity of 103 billion disposable gloves, with 70 billion nitrile gloves and 33 billion PVC gloves. In addition, the company produces approximately 1 million manual wheelchairs and 100,000 electric wheelchairs each year, supporting global demand for both protection and rehabilitation.

What makes INTCO Medical’s manufacturing system competitive globally?

INTCO Medical’s competitiveness comes from its large-scale production capacity, vertically integrated supply chain, advanced automation systems, and its ability to deliver consistent quality at global scale.

How does INTCO Medical ensure stable global supply?

Through a network of manufacturing bases and international marketing centers, INTCO Medical ensures supply stability and fast response capabilities across North America, Europe, and Asia, even under changing global demand conditions.

How is INTCO Medical expanding beyond its core glove business?

INTCO Medical is expanding by integrating Rehabilitation Medical Equipment and physical therapy products into its portfolio, creating a diversified healthcare solution system that supports both medical and long-term care needs.

How does innovation support INTCO Medical’s growth?

Innovation supports growth through continuous R&D investment, material and product development, and the integration of AI technologies that improve manufacturing efficiency and product quality.

What role does ESG play in INTCO Medical’s development?

ESG is a core part of INTCO Medical’s long-term strategy, guiding its efforts in sustainable manufacturing, energy optimization, and responsible global operations.

What is INTCO Medical’s long-term development focus?

INTCO Medical focuses on strengthening its global manufacturing scale, enhancing innovation capabilities, and building a more resilient healthcare supply system while maintaining leadership in non-latex gloves.


TOP